Chargement en cours...
Outcomes of autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma refractory to first line chemoimmunotherapy
Outcomes of patients with primary refractory diffuse large B cell lymphoma (DLBCL) are dismal. The role of autologous hematopoietic cell transplant (autoHCT) in this population is not well defined in the modern era. Most datasets combine these patients with those with relapsed disease. We report the...
Enregistré dans:
| Publié dans: | Transplant Cell Ther |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7965782/ https://ncbi.nlm.nih.gov/pubmed/32949754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.09.004 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|